[go: up one dir, main page]

TWI400042B - Food tablet - Google Patents

Food tablet Download PDF

Info

Publication number
TWI400042B
TWI400042B TW096120822A TW96120822A TWI400042B TW I400042 B TWI400042 B TW I400042B TW 096120822 A TW096120822 A TW 096120822A TW 96120822 A TW96120822 A TW 96120822A TW I400042 B TWI400042 B TW I400042B
Authority
TW
Taiwan
Prior art keywords
food
combination
lozenge
tablet
excipient
Prior art date
Application number
TW096120822A
Other languages
Chinese (zh)
Other versions
TW200847938A (en
Inventor
Yung Hsiang Lin
Hui Chuan Fu
Original Assignee
Tci Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tci Co Ltd filed Critical Tci Co Ltd
Priority to TW096120822A priority Critical patent/TWI400042B/en
Publication of TW200847938A publication Critical patent/TW200847938A/en
Application granted granted Critical
Publication of TWI400042B publication Critical patent/TWI400042B/en

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)

Description

食品錠劑Food lozenge

本發明係有關一種食品錠劑,特別是一種用以將目標成分以不同速率釋放出來之食品錠劑。The present invention relates to a food lozenge, and more particularly to a food lozenge for releasing the target ingredients at different rates.

由於錠劑型式具有服用方便、易於保存等優點,因此,錠劑應用於口服藥劑已相當普遍。一般而言,一種錠劑通常僅具有單一目的之功效,因此,若需要達到多種功效時,使用者便需服用多種錠劑。此外,依不同需求,即效性之錠劑以及長效性之錠劑亦被開發出來並應用於醫藥領域中。Because of the advantages of convenient dosage and easy storage, the tablet dosage is quite common for oral administration. In general, a lozenge usually only has a single purpose effect, so if a variety of effects are required, the user will need to take a variety of lozenges. In addition, depending on the needs, immediate lozenges and long-acting lozenges have also been developed and used in the pharmaceutical field.

然而,上述錠劑的應用方式在食品領域並不多見。舉例而言,一種習知之控制體重方式是在用餐前服用提供飽足感之錠劑以減少食量,並在用餐後服用促進代謝之錠劑以增加熱量消耗。對消費者而言,使用上並不便利。However, the application of the above-mentioned tablets is not common in the food field. For example, one conventional method of controlling body weight is to take a tablet that provides satiety before meals to reduce the amount of food, and to take a tablet that promotes metabolism after meals to increase calorie expenditure. For consumers, it is not convenient to use.

綜上所述,如何以單一食品錠劑即達到所需之不同目的及功效便是目前極需努力的目標。In summary, how to achieve the different purposes and effects required with a single food lozenge is the goal that is currently in great demand.

針對上述問題,本發明目的之一是提供一種食品錠劑,其結合快速崩解以及延緩釋放之技術,使目標成分以不同速率釋放出來。In view of the above problems, it is an object of the present invention to provide a food lozenge which combines rapid disintegration and delayed release techniques to release target ingredients at different rates.

為了達到上述目的,本發明一實施例之食品錠劑是用以將目標成分以不同速率釋放出來,其包含一第一層錠劑以及一第二層錠劑。第一層錠劑包含一第一有效成分、一第一控制釋放劑以及一第一賦形劑;第二層錠劑包含一第二有效成分、一第二控制釋放劑以及一第二賦形劑,其中,當食品錠劑被一使用者食用後,第一層錠劑於一預定時間內崩解,以釋放出第一有效成分,而第二層錠劑持續釋放第二有效成分之時間大於上述之預定時間。In order to achieve the above object, a food tablet according to an embodiment of the present invention is used to release a target ingredient at a different rate, and comprises a first layer tablet and a second layer tablet. The first tablet comprises a first active ingredient, a first controlled release agent and a first excipient; the second layer of the tablet comprises a second active ingredient, a second controlled release agent and a second shaped form The agent, wherein, when the food tablet is consumed by a user, the first layer of the tablet disintegrates within a predetermined time to release the first active ingredient, and the second layer of tablet continues to release the second active ingredient More than the predetermined time mentioned above.

以下藉由具體實施例配合所附的圖式詳加說明,當更容易瞭解本發明之目的、技術內容、特點及其所達成之功效。The purpose, technical contents, features, and effects achieved by the present invention will become more apparent from the detailed description of the appended claims.

本發明之一較佳實施例之食品錠劑是用以將目標成分以不同速率釋放出來。本發明之食品錠劑包含一第一層錠劑以及一第二層錠劑,其中第一層錠劑包含一第一有效成分、一第一控制釋放劑以及一第一賦形劑,第二層錠劑包含一第二有效成分、一第二控制釋放劑以及一第二賦形劑。利用快速崩解的配方設計,第一層錠劑被使用者食用後,在一預定時間內崩解而釋放出該第一成分。此外,亦利用延緩釋放的配方設計,使第二層錠劑可持續釋放第二成分,且持續釋放的時間大於第一層錠劑崩解的預定時間。A food lozenge according to a preferred embodiment of the invention is used to release the target ingredients at different rates. The food tablet of the present invention comprises a first layer tablet and a second layer tablet, wherein the first layer tablet comprises a first active ingredient, a first controlled release agent and a first excipient, and second The tablet comprises a second active ingredient, a second controlled release agent, and a second excipient. With the rapid disintegration formulation, the first layer of tablet is disintegrated within a predetermined time to release the first component after being consumed by the user. In addition, the delayed release formulation is also utilized to allow the second layer of tablet to sustain release of the second component for a sustained release time greater than the predetermined time for disintegration of the first layer of tablet.

於一實施例中,本發明之食品錠劑被食用後,第一層錠劑因具有快速崩解配方之效果以釋放出第一有效成分。舉例而言,第一控制釋放劑包含微結晶狀α-纖維素、交聯羧甲基纖維素鈉以及羧甲基澱粉鈉,較佳者,結晶狀α-纖維素、交聯羧甲基纖維素鈉以及羧甲基澱粉鈉佔第一層錠劑之重量百分比分別為10~30%、2~4%以及2~4%。於一實施例中,第一控制釋放劑更可包含海藻酸。In one embodiment, after the food tablet of the present invention is consumed, the first layer of the tablet has the effect of a fast disintegrating formulation to release the first active ingredient. For example, the first controlled release agent comprises microcrystalline α-cellulose, croscarmellose sodium, and sodium carboxymethyl starch, preferably, crystalline α-cellulose, crosslinked carboxymethyl fiber The sodium and sodium carboxymethyl starch accounted for 10 to 30%, 2 to 4%, and 2 to 4%, respectively, of the first layer of the tablet. In an embodiment, the first controlled release agent may further comprise alginic acid.

接續上述說明,第二層錠劑則利用延緩釋放的技術,延緩釋放的效果可利用將第二有效成分包覆於微粒中來達成;或是利用添加溼潤劑的方式,使第二層錠劑於水溶液中形成一水合層,藉由水合層的阻隔以延長第二有效成分釋放至水溶液的時間。舉例而言,第二控制釋放劑可為水溶膠體。於一實施例中,水溶膠體可為羥丙基甲基纖維素,例如羥丙基含量為7~12%,甲基含量為19~24%,黏度為4000~15000 cP之羥丙基甲基纖維素,較佳者,羥丙基甲基纖維素佔第二層錠劑之重量百分比為10~30%。Following the above description, the second layer of the tablet uses a delayed release technique, and the effect of delaying the release can be achieved by coating the second active ingredient in the particles; or by adding a wetting agent to make the second layer of the tablet. A monohydrate layer is formed in the aqueous solution by the barrier of the hydration layer to extend the time during which the second active ingredient is released to the aqueous solution. For example, the second controlled release agent can be a hydrosol. In one embodiment, the hydrosol may be hydroxypropyl methylcellulose, such as hydroxypropylmethyl having a hydroxypropyl group content of 7 to 12%, a methyl group content of 19 to 24%, and a viscosity of 4000 to 15000 cP. Cellulose, preferably, hydroxypropyl methylcellulose comprises from 10% to 30% by weight of the second layer of tablet.

第一賦形劑主要包含一疏水性稀釋劑,例如疏水性稀釋劑可為玉米澱粉、預膠化澱粉、磷酸氫鈣、磷酸二鈣或以上之組合。第二賦形劑主要包含親水性稀釋劑,例如親水性稀釋劑可為異麥芽酮糖醇、甘露醇、木糖醇、麥芽糖、乳糖、麥芽糊精、蔗糖、葡萄糖或以上之組合。The first excipient primarily comprises a hydrophobic diluent, for example the hydrophobic diluent can be corn starch, pregelatinized starch, dibasic calcium phosphate, dicalcium phosphate or a combination thereof. The second excipient primarily comprises a hydrophilic diluent, for example the hydrophilic diluent can be isomalt, mannitol, xylitol, maltose, lactose, maltodextrin, sucrose, glucose or a combination thereof.

此外,第一賦形劑以及第二賦形劑更可包含潤滑劑、黏合劑、流動控制劑、色素、乳化劑或以上之組合。舉例而言,潤滑劑可為硬脂酸鎂、硬脂酸鈣、聚乙二醇或以上之組合;黏合劑可為聚乙烯吡咯烷酮、澱粉、糊精、甲基纖維素或以上之組合;流動控制劑可為二氧化矽、滑石粉、矽鋁酸鈉或以上之組合;色素則可為天然色素或人工食用色素。Further, the first excipient and the second excipient may further comprise a lubricant, a binder, a flow control agent, a pigment, an emulsifier, or a combination thereof. For example, the lubricant may be magnesium stearate, calcium stearate, polyethylene glycol or a combination thereof; the binder may be polyvinylpyrrolidone, starch, dextrin, methylcellulose or a combination thereof; The controlling agent may be ceria, talc, sodium strontium aluminate or a combination thereof; the pigment may be a natural pigment or an artificial food coloring.

本發明較佳實施例之食品錠劑,其中之第一有效成分可為具有吸收使用者消化道內油脂及/或提供使用者飽足感功效的成分,例如甲殼素、植物纖維素或以上之組合,而第二有效成分則可為具有提供促進使用者之油脂分解及代謝速率功效的成分,例如瓜拿納萃取,或是具有抑制脂質或醣類代謝途徑功效的成分,例如藤黃果、大豆胜肽、武靴葉、青咖啡豆以及紫米萃取,亦或是上述兩種功效的組合。如此一來,使用者僅需於用餐前服用本發明之食品錠劑,即可產生飽足感並吸收用餐後攝入的油脂,且長時間具有促進代謝或抑制脂質或醣類代謝的效果。需注意者,上述實施例是以第一有效成分以及第二有效成分具有不同功效來作說明,然而,本發明之食品錠劑亦不排除應用於具有相同功效之第一有效成分以及第二有效成分,或是多種有效成分混合應用。The food tablet of the preferred embodiment of the present invention, wherein the first active ingredient may be an ingredient having the function of absorbing oil in the digestive tract of the user and/or providing a feeling of satiety of the user, such as chitin, plant cellulose or the like. The combination, and the second active ingredient may be a component having an effect of promoting decomposition and metabolic rate of the oil of the user, such as Guarana extraction, or an ingredient having an effect of inhibiting a lipid or carbohydrate metabolic pathway, such as Garcinia Cambogia, Soy peptides, stalks, green coffee beans, and purple rice extracts are also combinations of the above two effects. In this way, the user only needs to take the food tablet of the present invention before eating, thereby producing a feeling of satiety and absorbing the fat which is ingested after eating, and has an effect of promoting metabolism or inhibiting metabolism of lipids or sugars for a long period of time. It should be noted that the above embodiment is described by having different effects of the first active ingredient and the second active ingredient, however, the food tablet of the present invention is not excluded from being applied to the first active ingredient having the same efficacy and the second effective Ingredients, or a mixture of active ingredients.

以下揭露二個實例配方,經打錠製程以製成本發明之食品錠劑。Two example formulations are disclosed below which are subjected to a tableting process to form a food lozenge of the present invention.

實例1: Example 1:

實例2: Example 2:

綜合上述,依據本發明之食品錠劑結合快速崩解的即效性以及延緩釋放的長效性於單一錠劑,其可於食品領域產生多種應用方式,例如作為控制體重之代餐等,如此可增進使用者使用上的方便性。In summary, the food tablet according to the present invention combines the instant disintegration of rapid disintegration with the long-acting effect of delayed release in a single tablet, which can be used in various applications in the food field, for example, as a meal replacement meal, etc. It can enhance the convenience of users.

以上所述之實施例僅是為說明本發明之技術思想及特點,其目的在使熟習此項技藝之人士能夠瞭解本發明之內容並據以實施,當不能以之限定本發明之專利範圍,即大凡依本發明所揭示之精神所作之均等變化或修飾,仍應涵蓋在本發明之專利範圍內。The embodiments described above are only intended to illustrate the technical idea and the features of the present invention, and the purpose of the present invention is to enable those skilled in the art to understand the contents of the present invention and to implement the present invention. That is, the equivalent variations or modifications made by the spirit of the present invention should still be included in the scope of the present invention.

Claims (11)

一種食品錠劑,其用以控制體重,該食品錠劑包含:一第一層錠劑,其由:一第一有效成分,其為甲殼素、植物纖維素或以上之組合;一第一控制釋放劑,該第一控制釋放劑包含微結晶狀α -纖維素、交聯羧甲基纖維素鈉以及羧甲基澱粉鈉,其中該微結晶狀α -纖維素、該交聯羧甲基纖維素鈉以及該羧甲基澱粉鈉佔該第一層錠劑之重量百分比分別為10~30%、2~4%以及2~4%;及一第一賦形劑所組成;以及一第二層錠劑,其由:一第二有效成分,其為瓜拿納萃取、藤黃果、大豆胜肽、武靴葉、青咖啡豆、紫米萃取或以上之組合;一第二控制釋放劑,其包含佔該第二層錠劑之重量百分比為10~30%的羥丙基甲基纖維素;及一第二賦形劑所組成;其中,當該食品錠劑被一使用者食用後,該第一層錠劑於一預定時間內崩解,以釋放出該第一有效成分,而該第二層錠劑持續釋放該第二有效成分之時間係大於該預定時間。A food lozenge for controlling body weight, the food lozenge comprising: a first layer of lozenge comprising: a first active ingredient, which is chitin, plant cellulose or a combination thereof; a first control a release agent, the first controlled release agent comprising microcrystalline α -cellulose, croscarmellose sodium, and sodium carboxymethyl starch, wherein the microcrystalline α -cellulose, the crosslinked carboxymethyl fiber The sodium sodium and the sodium carboxymethyl starch account for 10 to 30%, 2 to 4%, and 2 to 4%, respectively, of the first layer of the tablet; and a first excipient; and a second a tableting agent comprising: a second active ingredient, which is a Guarana extract, a Garcinia Cambogia, a soybean peptide, a bootie leaf, a green coffee bean, a purple rice extract or a combination thereof; a second controlled release agent , comprising hydroxypropyl methylcellulose in an amount of 10 to 30% by weight of the second layer of the tablet; and a second excipient; wherein, after the food tablet is consumed by a user Dissolving the first layer of tableting agent for a predetermined period of time to release the first active ingredient, and the second layer of tableting agent continues The time for releasing the second active ingredient is greater than the predetermined time. 如請求項1所述之食品錠劑,其中該第一賦形劑為疏水性稀釋劑。 The food lozenge of claim 1, wherein the first excipient is a hydrophobic diluent. 如請求項2所述之食品錠劑,其中該疏水性稀釋劑為玉米澱粉、預膠化澱粉、磷酸氫鈣、磷酸二鈣或以上之組合。 The food lozenge of claim 2, wherein the hydrophobic diluent is corn starch, pregelatinized starch, calcium hydrogen phosphate, dicalcium phosphate or a combination thereof. 如請求項1至3之任一項所述之食品錠劑,其中該羥丙基甲基纖維素之羥丙基含量為7~12%,甲基含量為19~24%,黏度為4000~15000 cP。 The food tablet according to any one of claims 1 to 3, wherein the hydroxypropylmethylcellulose has a hydroxypropyl group content of 7 to 12%, a methyl group content of 19 to 24%, and a viscosity of 4000 to 4,000. 15000 cP. 如請求項1所述之食品錠劑,其中該第二賦形劑為親水性稀釋劑。 The food lozenge of claim 1, wherein the second excipient is a hydrophilic diluent. 如請求項5所述之食品錠劑,其中該親水性稀釋劑為異麥芽酮糖醇、甘露醇、木糖醇、麥芽糖、乳糖、麥芽糊精、蔗糖、葡萄糖或以上之組合。 The food lozenge of claim 5, wherein the hydrophilic diluent is isomalt, mannitol, xylitol, maltose, lactose, maltodextrin, sucrose, glucose or a combination thereof. 如請求項1所述之食品錠劑,其中該第一賦形劑為潤滑劑、黏合劑、流動控制劑、色素、乳化劑或以上之組合;該第二賦形劑為潤滑劑、黏合劑、流動控制劑、色素、乳化劑或以上之組合。 The food tablet according to claim 1, wherein the first excipient is a lubricant, a binder, a flow control agent, a pigment, an emulsifier or a combination thereof; the second excipient is a lubricant or a binder , a flow control agent, a pigment, an emulsifier or a combination of the above. 如請求項7所述之食品錠劑,其中該潤滑劑為硬脂酸鎂、硬脂酸鈣、聚乙二醇或以上之組合。 The food lozenge of claim 7, wherein the lubricant is magnesium stearate, calcium stearate, polyethylene glycol or a combination thereof. 如請求項7所述之食品錠劑,其中該黏合劑為聚乙烯吡咯烷酮、澱粉、糊精、甲基纖維素或以上之組合。 The food lozenge of claim 7, wherein the binder is polyvinylpyrrolidone, starch, dextrin, methylcellulose or a combination thereof. 如請求項7所述之食品錠劑,其中該流動控制劑為二氧化矽、滑石粉、矽鋁酸鈉或以上之組合。 The food lozenge of claim 7, wherein the flow control agent is ceria, talc, sodium strontium aluminate or a combination thereof. 如請求項7所述之食品錠劑,其中該色素為天然色素或人工食用色素。The food lozenge of claim 7, wherein the pigment is a natural pigment or an artificial food coloring.
TW096120822A 2007-06-08 2007-06-08 Food tablet TWI400042B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW096120822A TWI400042B (en) 2007-06-08 2007-06-08 Food tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW096120822A TWI400042B (en) 2007-06-08 2007-06-08 Food tablet

Publications (2)

Publication Number Publication Date
TW200847938A TW200847938A (en) 2008-12-16
TWI400042B true TWI400042B (en) 2013-07-01

Family

ID=44823680

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096120822A TWI400042B (en) 2007-06-08 2007-06-08 Food tablet

Country Status (1)

Country Link
TW (1) TWI400042B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254886B1 (en) * 1997-12-19 2001-07-03 Merck Patent Gmbh Multilayer tablet
TWI222885B (en) * 1999-12-20 2004-11-01 Schering Corp Extended release oral dosage composition
TWI265927B (en) * 2002-01-23 2006-11-11 Schering Corp Novel compounds as NS3-serine protease inhibitors of hepatitis C virus

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254886B1 (en) * 1997-12-19 2001-07-03 Merck Patent Gmbh Multilayer tablet
TWI222885B (en) * 1999-12-20 2004-11-01 Schering Corp Extended release oral dosage composition
TWI265927B (en) * 2002-01-23 2006-11-11 Schering Corp Novel compounds as NS3-serine protease inhibitors of hepatitis C virus

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
行政院衛生署食品資訊網,健康食品查驗登記現況,網址;http://food.fda.gov.tw/foodnew/info/InfoHealthFood.aspx?SN=29; *
金車甲殼素複方膠囊,網址;http://www.gco.com.tw/product/goods_detail.php?bid=&goods_id=1452 鐘喜男、許立人,藥劑學入門,昭仁出版社,中華民國六十三年八月初版 *

Also Published As

Publication number Publication date
TW200847938A (en) 2008-12-16

Similar Documents

Publication Publication Date Title
US6358526B1 (en) Method of making tablets and tablet compositions produced therefrom
CN102406679B (en) Traditional Chinese medicine American ginseng buccal tablet
CN101868228A (en) Orally disintegrating tablets
CN101309688A (en) Compositions and methods for sustained release of beta-alanine
JP7475393B2 (en) Tablet Composition
US20120015021A1 (en) Anti-appetite adhesive compositions
US8968768B2 (en) Phytosterol nutritional supplements
JP2013533881A (en) Pharmaceutical composition containing vanoxerin
CN102451162A (en) Olanzapine medicine absorbed through oral mucosa
TWI400042B (en) Food tablet
CN102727456B (en) Drug port cavity disintegrating tablet and preparation method thereof
US20080279931A1 (en) Composition for treatment of pain
JP7382409B2 (en) Method for the preparation of easy-to-take tablets containing dried ginkgo leaf extract
US10610556B2 (en) Compositions for regulation and control of appetite
CN100386071C (en) A medicine for treating cough and asthma and chronic bronchitis
JP2010270111A (en) Arginine-containing tablet
KR100857061B1 (en) Tablet containing Bachynium myrtilus extract and its preparation method
CA2639895C (en) Energizing compositions comprising goji, red clover and polygonum multiflorum, and uses thereof
CN107625875A (en) A kind of preparation method and purposes of Allium wallichii extract
JP6004702B2 (en) Method for producing solid preparation with reduced unpleasant taste
CN101590127B (en) Compound medicine containing total flavone of hawthorn (leaf) and folic acid compound
CN102048677A (en) Valganciclovir Hydrochloride solid preparation and preparation method thereof
JP2007302688A (en) Quick-acting formulation
US20080248136A1 (en) Acute and chronic heartburn composition and method
JP2026002788A (en) Pharmaceutical Composition